A. Ferlito et al., BASALOID-SQUAMOUS CELL-CARCINOMA OF THE LARYNX AND HYPOPHARYNX, The Annals of otology, rhinology & laryngology, 106(12), 1997, pp. 1024-1035
Basaloid squamous cell carcinoma (BSCC) is a recently described bimorp
hic variant of squamous cell carcinoma with distinct morphological and
biological features. We describe the clinicopathological findings, al
ong with immunohistochemical and ultrastructural investigations, in 15
new cases of BSCC of the larynx or hypopharynx observed and treated a
t the otolaryngology depart ment of the University of Padua between 19
89 and 1995, The world literature is also reviewed in order to develop
a more accurate clinicopathological profile of the tumor. Patient rec
ords and histologic slides were reviewed in all of our 15 cases. The p
atient group consisted of 13 men (86.67%) and 2 women with a mean age
of 63.33 years (median 69 years; range 44 to 84 years). Nine patients
presented with cervical lymph node metastases. Surgical treatment was
the therapy of choice; radiotherapy and chemotherapy have been applied
in different combinations. Follow-up was available on all 15 cases. L
ocal recurrence was described in 3 cases. Five of the 9 patients with
cervical lymph node metastases developed distant metastases. Distant s
pread of the tumor without lymph node involvement was observed during
follow-up in 4 cases. Nine patients died of disease, 2 are alive with
widespread metastases, 2 are alive with no evidence of disease, and 2
have died of other causes, The determined 5-year survival was estimate
d to be 17.5% by the Kaplan-Meier method. In conclusion, BSCC is a dis
tinctive carcinoma that is important to recognize, because it has a mo
re aggressive biological behavior than conventional squamous call carc
inoma.